Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098627 · ClinicalTrials.gov registry record · NA
The Effects of Laughter Therapy on Hemodialysis on Depression
A NA study, sponsored by Satellite Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT04098627 is a NA study that has completed, run by Satellite Healthcare. The registered enrollment target is 152 participants.
The verdict
NCT04098627, a NA study, has completed, sponsored by Satellite Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
End stage kidney disease is associated with increased depression. Laughter is associated with improvement in depression in chronic disease. The study objective was to measure the effect of intradialytic group laughter therapy on anxiety and depression. Pragmatic randomized controlled trial conducted in 10 hemodialysis centers in Northern California. The intervention group received a once weekly 30-minute long group laughter therapy session for 8 weeks. Primary outcome was depression score as measured using the Patient Health Questionnaire.
Interventions
- BEHAVIORAL Laughter Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2019-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04098627
The ClinicalTrials.gov registry entry for NCT04098627 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Satellite Healthcare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Laughter Therapy is the first listed.
NCT04098627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04098627 about?
NCT04098627 is a clinical study titled "The Effects of Laughter Therapy on Hemodialysis on Depression". End stage kidney disease is associated with increased depression. Laughter is associated with improvement in depression in chronic disease. The study objective was to measure the effect of intradialytic group laughter therapy on anxiety and depression. Pragmatic randomized controlled trial conducted...
What is the current status of trial NCT04098627?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2018-04-01. Estimated completion is 2019-03-28.
What interventions are being tested in trial NCT04098627?
The interventions under investigation include: Laughter Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04098627?
This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.